Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Checkmate Pharmaceuticals, Inc. See All Filings	D	2020-06-18 16:38:40 UTC
Amount To Be Raised $100,083,274 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-20-000004 Exclusions or Exemptions 506b Accepted Date 2020-06-18 16:38:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D	2020-04-24 11:30:59 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-04-24 11:30:59 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Checkmate Pharmaceuticals, Inc. See All Filings	D/A	2020-01-28 08:45:57 UTC
Amount To Be Raised $15,999,999 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-01-28 08:45:57 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D	2019-08-20 15:13:06 UTC
Amount To Be Raised $15,999,999 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-19-000005 Exclusions or Exemptions 506b Accepted Date 2019-08-20 15:13:06 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D/A	2019-04-01 09:56:48 UTC
Amount To Be Raised $21,999,995 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-19-000004 Exclusions or Exemptions 506b Accepted Date 2019-04-01 09:56:48 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D	2018-12-12 09:49:23 UTC
Amount To Be Raised $21,999,995 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-18-000003 Exclusions or Exemptions 506b Accepted Date 2018-12-12 09:49:23 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D	2017-06-15 17:34:50 UTC
Amount To Be Raised $27,000,000 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-06-15 17:34:50 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D/A	2017-02-16 16:08:15 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-02-16 16:08:15 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D/A	2016-06-30 14:22:00 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-06-30 14:22:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Checkmate Pharmaceuticals, Inc. See All Filings	D	2015-08-19 00:00:00 UTC
Amount To Be Raised $20,030,000 Associated Brokers / Dealers N/A CIK Number 0001651431 Filed Document 0001651431-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-08-19 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity